Status:

UNKNOWN

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients

Lead Sponsor:

Zhejiang University

Conditions:

Chronic Hepatitis B

Hepatic Steatosis

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

To investigate the influence of hepatic steatosis on the anti-viral effect of entecavir in chronic hepatitis B patients.

Detailed Description

Chronic hepatitis B (CHB) affects approximately 360 million persons worldwide and is the most common cause of liver disease and affects over 10% of the general population in China. Hepatic steatosis i...

Eligibility Criteria

Inclusion

  • Patients should be diagnosed with chronic hepatitis B infection and hepatic steatosis
  • CHB infection
  • HBV-DNA ≥ 1×105 copies/ml;
  • HBeAg positive ;
  • ALT between the 2-10 times of the upper limit level
  • hepatic steatosis According to the "Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary", with test of CT scan or B ultrasound and confirmation of liver biopsy(in portion of patients)

Exclusion

  • those receiving antiviral treatment before the study
  • those on hepatoxic drug treatment,
  • those consuming alcohol regularly or excessively,
  • those diagnosed of cirrhosis, anti-HCV or anti-Delta positive patients,
  • those diagnosed as having autoimmune or other metabolic liver diseases
  • those have wilson's disease, PBC, PSC, IBD and other diseases that may influence the process and effect of therapy
  • those who are pregnant, have mental disorder and were received anti-viral treatment

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2012

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT01148576

Start Date

June 1 2010

End Date

February 1 2012

Last Update

June 22 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The first affiliated hospital, college of medicine, zhejiang university

Hangzhou, Zhejaing, China, 310003

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients | DecenTrialz